Literature DB >> 526732

Pharmacokinetics of disopyramide administered by intramuscular, intravenous and oral routes to normal volunteers [proceedings].

J J Ashford, D Carmichael, P H Kidner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 526732      PMCID： PMC2043680     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  4 in total

1.  The pharmacokinetics of Norpace.

Authors:  A Karim
Journal:  Angiology       Date:  1975-01       Impact factor: 3.619

2.  The pharmacokinetics of disopyramide following myocardial infarction with special reference to oral and intravenous dose regimens.

Authors:  J W Ward; G R Kinghorn
Journal:  J Int Med Res       Date:  1976       Impact factor: 1.671

3.  Simple gas-liquid chromatographic method for the measurement of disopyramide in blood-plasma or serum and in urine.

Authors:  A M Hayler; R J Flanagan
Journal:  J Chromatogr       Date:  1978-06-11

4.  Disopyramide serum and pharmacologic effect kinetics applied to the assessment of bioavailability.

Authors:  S M Bryson; B Whiting; J R Lawrence
Journal:  Br J Clin Pharmacol       Date:  1978-11       Impact factor: 4.335
  4 in total
  2 in total

Review 1.  Clinical pharmacokinetics of disopyramide.

Authors:  A Karim; C Nissen; D L Azarnoff
Journal:  J Pharmacokinet Biopharm       Date:  1982-10

Review 2.  Disopyramide. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiac arrhythmias.

Authors:  R N Brogden; P A Todd
Journal:  Drugs       Date:  1987-08       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.